use of nibadi yoga in the treatment of white discharge through vagina

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2012
INTERVENTION: Intervention1: nimbadi varti: In the present study all the patients will be randomly divided into two groups Minimum number of the patients to each group will be 50 GROUP A In this group patients will be treated with Yonivarti Nimbadi Yoga GROUP B In this group patients will be treated with Vaginal suppository Clingen having Clindamycin 100mg Clotrimazole 100mg Soft Gelatin Base Intervention2: nimbadi varti and clingen: In the present study all the patients will be randomly divided into two groups Minimum number of the patients to each group will be 50 GROUP A In this group patients will be treated with Yonivarti Nimbadi Yoga GROUP B In this group patients will be treated with Vaginal suppository Clingen having Clindamycin 100mg Clotrimazole 100mg Soft Gelatin Base Intervention3: nimbadi varti as vaginal suppository: In the present study all the patients will be randomly divided into two groups Minimum number of the patients to each group will be 50 GROUP A In this group patients will be treated with Yonivarti Nimbadi Yoga GROUP B In this group patients will be treated with Vaginal suppository Clingen having Clindamycin 100mg Clotrimazole 100mg Soft Gelatin Base Intervention4: nimbadi varti: DRUGS: No. DRUG LATIN NAME RATIO 1. Nimba patra Azadirecta indica 200gm 2. Triphala‐ 1. Haritaki‐ 2. Vibhitaki‐ 3. Amalaki‐ ‐Terminalia chebula Retz. ‐Terminalia belerica Rox ‐Emblika officinalis Geartn. 50gm 3. Jala ‐ 1500ml Avasesh ‐ 1000ml 5 Prakshep â??Madhu ‐ Spatika 20ml 05gm Total 1020ml Intervention5: Nimbadi yoga Yonivarti : DOSE‐1 tab. of 3gm, root of administration as Vaginal suppository, DURATION 14 days Control Intervention1: clingen: In this group patients will be treated with Vaginal CONDITION: vaginal discharge PRIMARY OUTCOME: drug standardization‐‐‐‐‐‐Timepoint: 15 months SECONDARY OUTCOME: public interest‐‐‐‐‐‐Timepoint: 16 months INCLUSION CRITERIA: Married woman. The patient having clinical sign & symptoms of swetapradar. The patient having positive causative organism by wet smear test
Epistemonikos ID: ab6604d650f552b76b13a87d08c42eaa2be36521
First added on: Aug 22, 2024